NYSE · SMGMaterialsAgricultural Chemicals

The Scotts Miracle-Gro financials

$49.50+2.19%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ3 '26
Jun 27
Q2 '26
Mar 28
Q1 '26
Dec 27
Q4 '25
Sep 30
Q3 '25
Jun 28
Q2 '25
Mar 29
Q1 '25
Dec 28
Q4 '24
Sep 30
Q3 '24
Jun 29
Q2 '24
Mar 30
Q1 '24
Dec 30
Q4 '23
Sep 30
Revenue$1.17B$1.46B$354.4M$387.3M$1.16B$1.39B$366.6M$414.7M$1.20B$1.53B$410.4M$374.5M
Gross profit$365.9M$610.5M$88.7M$23.5M$372.7M$542.1M$88.5M-$29.5M$354.1M$463.7M$62.2M-$218.8M
Gross margin31.2%41.8%25.0%6.1%32.1%39.0%24.1%−7.1%29.5%30.4%15.2%−58.4%
Operating income$169.6M$401.8M-$21.8M-$131.3M$221.8M$349.7M-$45.8M-$196.2M$200.1M$282.9M-$47.3M-$416.1M
Net income$112.2M$238.6M-$125.0M-$151.9M$149.1M$217.5M-$69.5M-$244.0M$132.1M$157.5M-$80.5M-$468.4M
Net margin9.6%16.3%−35.3%−39.2%12.9%15.7%−19.0%−58.8%11.0%10.3%−19.6%−125.1%
Diluted EPS$1.90$4.04$-2.16$-2.51$2.54$3.72$-1.21$-4.43$2.28$2.74$-1.42$-8.45
EBITDA$233.3M$420.1M-$1.6M-$79.0M$239.4M$379.1M-$10.4M-$107.5M$219.7M$305.1M-$34.3M-$307.3M
Operating cash flow$345.6M$220.0M-$370.4M$174.1M$454.4M$188.1M-$445.3M$118.5M$588.0M$304.2M-$343.2M$535.3M
Free cash flow$321.1M$201.4M-$390.4M$131.2M$437.5M$179.8M-$474.6M$101.9M$574.8M$287.9M-$381.1M$516.3M
Diluted shares59.2M59.1M57.9M60.5M58.6M58.4M57.3M55.1M58.0M57.4M56.7M55.4M

Balance sheet

Period endJun 27Mar 28Dec 27Sep 30Jun 28Mar 29
Cash & equivalents$27.7M$6.2M$8.3M$32.8M$51.1M$8.7M
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$2.11B$2.35B$2.53B$2.11B$2.19B$2.55B
Total assets$3.17B$3.41B$3.03B$2.74B$3.09B$3.54B
Total liabilities$3.38B$3.70B$3.53B$3.10B$3.26B$3.83B
Shareholders' equity-$208.7M-$286.5M-$500.6M-$357.5M-$170.9M-$290.1M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology